Page last updated: 2024-10-24

carmustine and Libman-Sacks Disease

carmustine has been researched along with Libman-Sacks Disease in 2 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meloni, G1
Capria, S1
Vignetti, M1
Mandelli, F1
Modena, V1
White, JP1
Ward, MJ1

Reviews

1 review available for carmustine and Libman-Sacks Disease

ArticleYear
Drug-induced adverse pulmonary reactions.
    Adverse drug reactions and acute poisoning reviews, 1985,Winter, Volume: 4, Issue:4

    Topics: Amiodarone; Asthma; Bleomycin; Carmustine; Drug-Related Side Effects and Adverse Reactions; Gold; Hu

1985

Other Studies

1 other study available for carmustine and Libman-Sacks Disease

ArticleYear
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
    Blood, 1997, Jun-15, Volume: 89, Issue:12

    Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Blast Crisis;

1997